Lunch Industry Session†: Moving Forward: An Informed Approach to the Diagnosis and Treatment of Tardive Dyskinesia
Sponsored by Neurocrine Biosciences, Inc.
— International Center
Greg Mattingly, MD
Lunch Industry Session†: The Science of TAAR1: A Potential New Target in Psychiatric Disorders
Sponsored by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.
— Colorado Hall
Rakesh Jain, MD, MPH and Craig Chepke, MD DFAPA